While OS is still the king of the oncology endpoints, experts note it may soon be phased out due to the introduction of ...

Study did not meet primary endpoint of complete healing of PCED at Week 8; secondary endpoints also did not achieve ...

Federal agencies across civilian, defense, and financial sectors face growing risks at the endpoint—from nation-state actors ...

Enata Pharmaceuticals said it didn't meet its primary endpoint in a Phase 2b study of zelicapavir, its proposed treatment for Respiratory Syncytial Virus, or RSV, in high-risk adults.

Researchers hope that changes to total hip BMD will get approval from the FDA as a surrogate endpoint for clinical trials of ...

Enanta Pharmaceuticals remains a Buy as zelicapavir shows promise in RSV trials; strong financials support growth. Read why ...

SA announced results from the first of two late-breaking presentations at the United European Gastroenterology, UEG, Meeting in ...

Enanta is advancing zelicapavir to Phase III trials after CMO Dr Scott Rottinghaus said it is justified by the Phase IIb data ...

​Microsoft is working to resolve a bug that causes Defender for Endpoint to incorrectly tag some devices' BIOS (Basic ...

A multicenter phase 3 trial comparing ocrelizumab to fingolimod for children with MS achieved its noninferiority primary ...

Kala Bio missed the primary endpoint in the study for its treatment of Persistent Corneal Epithelial Defect, an eye defect, and said it would stop development of the drug, called KPI-012. The company ...

Protecting critical systems calls for a disciplined approach that mirrors battlefield tactics in its emphasis on awareness, ...